Annals of Oncology

In this issue:

In this issue
Ann Oncol 7: 427.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 7: 427.
[PDF] [Request Permissions]

News:

Heated debate on drug policy in Holland and Switzerland
Ann Oncol 7: 428.
[PDF] [Request Permissions]

New FDA rules: ASCO applauds, mixed reaction in Europe
Ann Oncol 7: 428-430.
[PDF] [Request Permissions]

Chernobyl: After ten years, consequences are showing up
Ann Oncol 7: 430.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 7: 430-431.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 7: 431.
[PDF] [Request Permissions]

Book reviews:

Walter Felix Jungi

Book review
Ann Oncol 7: 432.
[PDF] [Request Permissions]

J. Bernier

Book review
Ann Oncol 7: 541-542.
[PDF] [Request Permissions]

A. Kiss

Book review
Ann Oncol 7: 543-544.
[PDF] [Request Permissions]

Editorials:

Giorgio Cocconi

New generation of aromatase inhibitros: Prospects of a major advantage for the patients
Ann Oncol 7: 433-437.
[PDF] [Request Permissions]

Peter Boyle

Continual importance of descriptive epidemiology in cancer research
Ann Oncol 7: 439-440.
[PDF] [Request Permissions]

Giampietro Gasparini and Marco Presta

Clinical studies with angiogenesis inhibitors: Biological rationale and challenges for their evaluation
Ann Oncol 7: 441-444.
[PDF] [Request Permissions]

Special articles:

T. A. Connors

Is there a future for cancer chemotherapy?: The Michel Clavel lecture
Ann Oncol 7: 445-452.
[PDF] [Request Permissions]

Review:

K. Öberg

Neuroendocrine gastrointestinal tumours
Ann Oncol 7: 453-463.
[Abstract] [PDF] [Request Permissions]

Original articles:

C. I. Falkson and H. C. Falkson

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer
Ann Oncol 7: 465-469.
[Abstract] [PDF] [Request Permissions]

B. Thürlimann, K. Beretta, M. Bacchi, M. Castiglione-Gertsch, A. Goldhirsch, W. F. Jungi, F. Cavalli, H.-J. Senn, M. Fey, T. Löhnert, and Swiss Group for Clinical Cancer Research (SAKK)

First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer: Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
Ann Oncol 7: 471-479.
[Abstract] [PDF] [Request Permissions]

M. Zambetti, P. Valagussa, and G. Bonadonna

Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer: Updated results
Ann Oncol 7: 481-485.
[Abstract] [PDF] [Request Permissions]

P. F. Conte, E. Baldini, G. Gardin, P. Pronzato, D. Amadori, F. Carnino, C. Monzeglio, P. Gentilini, P. Gallotti, R. De Micheli, M. Venturini, A. Rubagotti, R. Rosso, and North-West Oncology Group (GONO) Italy

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)
Ann Oncol 7: 487-490.
[Abstract] [PDF] [Request Permissions]

S. G. Eckhardt, H. A. Burris, J. R Eckardt, G. Weiss, G. Rodriguez, M. Rothenberg, D. Rinaldi, R. Barrington, J. G. Kuhn, K. Masuo, K. Sudo, R. Atsumi, T. Oguma, L. Higashi, S. Fields, L. Smetzer, and D. D. Von Hoff

A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium
Ann Oncol 7: 491-496.
[Abstract] [PDF] [Request Permissions]

F. Levi, V. C. Te, L. Randimbison, and C. La Vecchia

Trends in cancer incidence and mortality in Vaud, Switzerland, 1974–1993
Ann Oncol 7: 497-504.
[Abstract] [PDF] [Request Permissions]

A. N. M. Wymenga, W. T. A. van der Graaf, J. A. Wils, L. Siegenbeek van Heukelom, G. H. M. van der Linden, A. C. Dullemond-Westland, M. Nooy, C. van der Heul, K. M. de Bruijn, and E. G. E. de Vries

A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy
Ann Oncol 7: 505-510.
[Abstract] [PDF] [Request Permissions]

E. Pras, P. H. B. Willemse, H. Boonstra, H. Hollema, M. A. A. M. Heesters, B. G. Szabó, H. W. A. de Bruijn, J. G. Aalders, and E. G. E. de Vries

Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix
Ann Oncol 7: 511-516.
[Abstract] [PDF] [Request Permissions]

P. Kosmidis, N. Mylonakis, G. Fountzilas, N. Pavlidis, E. Samantas, A. Karabelis, K. Kattis, D. Skarlos, and Hellenic Co-Operative Oncology Group

A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)
Ann Oncol 7: 517-520.
[Abstract] [PDF] [Request Permissions]

Clinical case:

C. A. H. H. V. M. Verhagen, Q. G. C. M. van Hoesel, C. P. T. Schijf, and P. H. M. De Mulder

The management of granulosa cell tumor of the ovary — a case history
Ann Oncol 7: 521-524.
[PDF] [Request Permissions]

Short reports:

J. M. Tourani, V. Lucas, D. Mayeur, B. Dufour, M. Di Palma, C. Boaziz, P. Grise, C. Varette, J. M. Pavlovitch, E. Pujade-Lauraine, D. Larregain, E. Ecstein, M. Untereiner, E. Vuillemin, S. Merran, and J. M. Andrieu

Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma: Results of a multicenter SCAPP1 trial
Ann Oncol 7: 525-528.
[Abstract] [PDF] [Request Permissions]

N. Pavlidis, A. R. Hanauske, T. Gamucci, J. Smyth, M. Lehnert, A. te Velde, J. Lan, and J. Verweij

A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC Early Clinical Studies Group (ECSG)
Ann Oncol 7: 529-531.
[Abstract] [PDF] [Request Permissions]

T. C. Kok, A. van der Gaast, T. A. W. Splinter, and Rotterdam Esophageal Tumor Study Group

5-Fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area
Ann Oncol 7: 533-534.
[Abstract] [PDF] [Request Permissions]

Letters:

S. S. Sikora, M. E. Sarnsonov, K. A. Dookeran, H. Edington, and M. T. Lotze

Peripheral nerve entrapment: An unusual adverse event with high-dose interleukin-2 therapy
Ann Oncol 7: 535-536.
[PDF] [Request Permissions]

M. E. Stein, Z. Bernstein, K. Drumea, A. Eyal, G. M. Groisman, J. Lachter, and N. Haim

Intra-abdominal abscess and tumor-enteric fistula formation: An unusual complication of chemotherapy for advanced testicular choriocarcinoma
Ann Oncol 7: 536-537.
[PDF] [Request Permissions]

S. Brugnatelli, A. Riccardi, G. Ucci, M. Petrini, M. Giordano, L. Barbarano, C. Bergonzi, A. De Paoli, L. Cavanna, E. Ascari, and Cooperative Group of Study and Treatment of Multiple Myeloma

Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: A pilot study
Ann Oncol 7: 537-538.
[PDF] [Request Permissions]

S. Cascinu, E. Del Ferro, M. Ligi, F. Graziano, A. Castellani, and G. Catalano

Phase II trial of 13-cis retinoic acid plus interferon- in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy
Ann Oncol 7: 538-539.
[PDF] [Request Permissions]

Advertisements in this issue:

21st ESMO Congress
Ann Oncol 7: 545.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 7: 546.
[PDF] [Request Permissions]

Kluwer Academic Publishers
Ann Oncol 7: 547.
[PDF] [Request Permissions]

Bristol-Meyers Squibb
Ann Oncol 7: 547.
[PDF] [Request Permissions]

ESMO applications for membership
Ann Oncol 7: 547.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.